Sivopixant |
Antagonist of P2RX3
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| P2RX3 |
|
Antagonist
100 nM
Selectivity
In Cell Selectivity Assessment
Selectivity Assessment Description:
In cell inhibitory activity IC50 >30000 nM for P2X1, P2X2, P2X4, P2X7
while P2X2/3 had IC50 1100 nM ...
Potency Cellular
In Vitro
P2RX3
Mode of Action: Antagonist
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1016/j.bmcl.2021.128384
In Vivo Validations
Rat
Dose: 1 mg/kg
Route of delivery:
Intravenous
Plasma half life:
10.1 h
Systemic clearance:
2.7 mL/min/kg
Fb :
99 %
DOI Reference: 10.1016/j.bmcl.2021.128384
Dose: 3 mg/Kg
Route of delivery:
Oral
Cmax:
1630 ng/mL
Area Under the Curve::
14000 ng*hr/mL
Bioavailability:
76.8 %
Target engagement assay:
strong analgesic effect in the rat Seltzer model of allodynia (ED50 0.4 mg/kg)
DOI Reference: 10.1016/j.bmcl.2021.128384
Chemical Information
| Molecular Formula | C25H22ClN5O5 |
| SMILEs | C[C@@H](Cn1c(=O)nc(Nc2ccc(Oc3ccccn3)cc2)n(Cc2ccc(Cl)cc2)c1=O)C(=O)O |
| InChI | InChI=1S/C25H22ClN5O5/c1-16(22(32)33)14-31-24(34)29-23(30(25(31)35)15-17-5-7-18(26)8-6-17)28-19-9-11-20(12-10-19)36-21-4-2-3-13-27-21/h2-13,16H,14-15H2,1H3,(H,32,33)(H,28,29,34)/t16-/m0/s1 |
| Molecular weight | 507.13 Da |
| AlogP | 0.0 |
| HBond acceptors | 10 |
| HBond donors | 2 |
| Atoms | 58 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.